Cardiovascular-kidney-metabolic health: a presidential advisory from the American Heart Association

Ndumele, Chiadi E., Rangaswami, Janani, Chow, Sheryl L., Neeland, Ian J., Tuttle, Katherine R., Khan, Sadiya S., Coresh, Josef, Mathew, Roy O. +22 more·2023·Circulation
DOI 10.1161/cir.0000000000001184

Cited by (1,000)

Items 601–700 of 1,000

  1. The Correlation Between Triglyceride-Glucose Index and Its Associated Indices With All-Cause and Cardiovascular Mortality in Patients With Advanced-Stage Cardiovascular-Kidney-Metabolic Syndrome
    Zhaoqi Yan, Yifeng Xu, Xiufan Du · 2025 · Heart Lung and Circulation
  2. Association of the metabolic dysfunction-associated steatotic liver disease with cardiovascular and kidney disease in patients with type 2 diabetes mellitus: a cross-sectional study
    Huihui Ren, Mengyuan Hu, Yongli Yan, Mengke Cheng, Chengru Yang, Gang Yuan, Tingting Du · 2025 · Diabetes Research and Clinical Practice
  3. Metabolic health of the population: a modern view of the problem and solutions
    Galina A. Chumakova, Т. Yu. Kuznetsova, М. A. Druzhilov, О. В. Гриценко · 2024 · Russian Journal of Cardiology
  4. Social Determinants of Health for Cardiovascular-Kidney-Metabolic Syndrome Among Patients With Diabetes
    Kibret Enyew Belay, Yeweyenhareg Feleke, Theodros Aberra Alemneh, Asteway Mulat Haile, Desalegn Abebe · 2024 · Journal of the Endocrine Society
  5. The role of cardiovascular disease in the association between estimated glucose disposal rate and chronic kidney disease
    Yihuan Chen, Lei Zheng, Ying Zhou, Yucheng Hou, Yihong Zhou, Han Shen · 2025 · Scientific Reports
  6. NIH cuts: a costly retreat-defunding precision lifestyle medicine amid the cardiovascular-kidney-metabolic crisis
    Zacharias Papadakis · 2025 · American Journal of Physiology-Heart and Circulatory Physiology
  7. Race, Racism, and Risk—Implications of Social Determinants of Health in Cardiovascular Disease Prediction
    Sadiya S. Khan, Clyde W. Yancy · 2023 · JAMA Cardiology
  8. Cardiometabolic Risk
    Abhayjit Singh, Dennis Bruemmer · 2024 · JACC Advances
  9. Chronic Kidney Disease Progression in Heart Failure
    Hiddo J.L. Heerspink, Brendon Lange Neuen, Lesley A. Inker · 2024 · JACC Heart Failure
  10. Incidence of cardiovascular-kidney-metabolic syndrome and its risk factors for progression in China
    Aomiao Chen, Qiuyu He, Yichuan Wu, Jiaqi Chen, Xiaoqin Ma, Geningyue Wang, Lingyuan Hu, Zhuotong Wang, Jinming Huang, Xinran Xie et al. · 2024 · medRxiv
  11. Kidney Transplant: More than Immunological Problems
    Rosana Gelpi, Ángela Casas, Omar Taco, Maya Sánchez-Baya, Mohamed Nassiri, Mónica Bolufer, Javier Paúl, María Molina, Laura Cañas, Anna Vila et al. · 2025 · Journal of Clinical Medicine
  12. Association between the life’s essential 8 health behaviors score and all-cause mortality in cardiovascular-kidney-metabolic syndrome patients
    Dingyuan Tu, Xiaoli Zuo, Ping Li, Jianming Wang · 2025 · Frontiers in Nutrition
  13. Early-Life Prevention of Cardiovascular–Kidney–Metabolic Syndrome: The DOHaD Perspective on Resveratrol and Short-Chain Fatty Acids
    Chien‐Ning Hsu, Ying-Jui Lin, Chih‐Yao Hou, Yu‐Wei Chen, You‐Lin Tain · 2025 · Antioxidants
  14. Role of depressive symptoms in accelerating cardiovascular diseases progression in cardiovascular-kidney-metabolic syndrome stages 0–3: A nationwide prospective cohort study
    Cui Ma, Defeng Zhao, Lu Zhai, Rong‐Rui Huo, Yuhua Liu · 2025 · General Hospital Psychiatry
  15. Interdisciplinary recommendations for recurrent hyperkalaemia: insights from the GUARDIAN-HK European Steering Committee
    Gianluigi Savarese, María Jesús Izquierdo, Clara Bonanad, Aaron Wong, Roland Schmitt, Pietro Manuel Ferraro, Francesco Dentali, James O. Burton, Giuseppe M.C. Rosano · 2025 · European Heart Journal - Cardiovascular Pharmacotherapy
  16. The Advanced Lung Cancer Inflammation Index and Mortality in Patients with Cardiovascular-Kidney Metabolic Syndrome: Insights from NHANES
    Xiaohan Ma, Xin Tang, Sheng Chen, Tong Wu, Peiling Zuo, Fasheng Wu, Encun Hou, Xiaofei Zhang · 2025 · BMC Cardiovascular Disorders
  17. Mapping the current research landscape of metformin in cancer based on bibliometric analysis
    Yuan Wang, Sike He, Zhi Li, Nan Jiang, Guangxi Sun · 2025 · Discover Oncology
  18. Cardiovascular disease risk estimates for primary prevention in the US prediabetes and diabetes population using the PREVENT equation
    Xunliang Li, Wenman Zhao, Zhao Li, Tongxin Sun, Hai‐Feng Pan, Deguang Wang · 2025 · Diabetes Obesity and Metabolism
  19. Contemporary and Emerging Therapeutics in Cardiovascular-Kidney-Metabolic (CKM) Syndrome: In Memory of Professor Akira Endo
    Inderjeet Singh Bharaj, Karen Purewal, Juzer Munaim, Ajit Singh Brar, Aayushi Kacheria, Austin Simister, Umabalan Thirupathy, Palak Gupta, Jasraj Kahlon, Ei Ei Thwe et al. · 2025 · Biomedicines
  20. The prevention of adult cardiovascular disease must begin in childhood: evidence and imperative
    Michael Khoury, Adam L. Ware, Brian W. McCrindle · 2025 · Nature Reviews Cardiology
  21. The Role of Insulin Resistance in Cardiorenal Metabolic Syndrome
    Jiquan Xiao, Wen Long Song, Yusi Huang, Xiang He, Yihan Weng, Huimin Yu · 2025 · Cardiology in Review
  22. Novel adiposity indices and their associations with all-cause and cardiovascular mortality in individuals with cardiovascular–kidney–metabolic syndrome stages 0–3: findings from a nationwide prospective cohort study
    Hangyu Zhou, Yingying Xing, Tingting Wang, Tiantian Wang, Saiyaremu Xierzhati, Diliyaer Adili, Zhao Wang, Jie Li · 2025 · Frontiers in Endocrinology
  23. Chronic kidney disease confers increased excess risks of mortality and cardiovascular events in women compared with men
    Zhejia Tian, Uta Hillebrand, Janis Casper, Kai Martin Schmidt-Ott, Anette Melk, Bernhard M. W. Schmidt · 2025 · Nephrology Dialysis Transplantation
  24. Meta-analysis of the impact of statins on change in renal function in patients with moderate or severe chronic kidney disease
    Deepak Vedamurthy, Usman Sagheer, Mahima Tyagi, Kevin Carl Maki, Dinesh K. Kalra · 2025 · Journal of clinical lipidology
  25. Frailty and Its Progression With Cardiovascular Disease Risk With Cardiovascular-Kidney-Metabolic Syndrome Stages 1 to 3
    Qianrong Zheng, Jiaxin Shao, Jiayi Teng, Jijie Jin, Dmitry Abramov, Ashish Verma, Ying Xu, Qianqian Zhu, Jiangnan Yao, Jingwei Lv et al. · 2025 · JACC Advances
  26. Clinical and laboratory characteristics of novel diabetes subgroups: A systematic review and meta-analysis
    Na Ao, Jia Li, Qian Wang, Jian Du, Shi Jin, Jing Yang · 2025 · Scientific Reports
  27. Association of air pollutions and systemic inflammation with early cardiovascular-kidney-metabolic syndrome among middle-aged and elderly adults: a cross-sectional study from CHARLS
    Xuanming Xu, Lian Tang, Yutong Kang, Jing Liang, Wenqi Geng, Yajie Wang · 2025 · Scientific Reports
  28. Plant-based diet and mortality in adults with cardiovascular-kidney-metabolic syndrome: evidence from NHANES with mediation by leukocyte telomere length
    Zhuotao Xiao, Fengling Chen, Ying Yin, Bing You, Yilin Wang, Bo Sun · 2025 · Renal Failure
  29. Albuminuria is Associated with Worse Outcomes in Non-Diabetics Hospitalized with Acute Heart Failure
    Yoshimitsu Takaoka, Yu Horiuchi, Michael Strader, Patrick T. Murray, Nicholas W. Wettersten · 2025 · ESC Heart Failure
  30. Dietary antioxidants and CKM–depression comorbidity: a primary analysis with a secondary evaluation of all-cause mortality using six machine learning algorithms
    Yi Tang, Zilong Yue, Juncang Wu, Hongwei Liu, Qiuwan Liu, Kangrui Zhang, Yueyu Zhang, Yu Wang, Shuaizhou Wang, Xinyi Chen et al. · 2025 · European journal of medical research
  31. Risk Assessment in Cardiovascular-Kidney-Metabolic Syndrome
    L. Parker Gregg, Biykem Bozkurt, Sankar D. Navaneethan · 2025 · Clinical Journal of the American Society of Nephrology
  32. 2025 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guideline for the Primary Care Management of Chronic Kidney Disease
    Amy R. Schwartz, Jonathan A. Sosnov, Jonathan Brown, Cynthia Delgado, Linda F. Fried, Manjula Kurella Tamura, John W. Morrison, Sankar Dass Navaneethan, Paul M. Palevsky, Diane B. Rybacki et al. · 2025 · Annals of Internal Medicine
  33. Triglyceride glucose index and atherogenic index of plasma predict rapid kidney function decline in cardiovascular–kidney–metabolic syndrome: the first longitudinal evidence from CHARLS
    Xueqi Chen, Yifan Wang, Mengying Dong, Yao Ma, Yun Bo, Yan Wang, Xueyi Xia, Wei Zhao, Xiaohua Pei · 2025 · European journal of medical research
  34. Association between cardiovascular-kidney-metabolic syndrome and risks of 14 age-related health outcomes in primary prevention older population
    Zhen Zhou, Kevan Roy Polkinghorne, Andrew M. Tonkin, Robyn L. Woods, Anping Cai, Sophia Zoungas, Michelle A. Fravel, Michael E. Ernst, Chao Zhu, Mark Raymond Nelson et al. · 2026 · GeroScience
  35. Cell membrane-coated nanoparticles target multiorgan crosstalk in cardiovascular-kidney-metabolic syndrome
    Junyan Zhang, Sibei Tao, Jiaojiao Yang, Ping Fu, Zhongxiu Chen, Li Rao, Siying Tao, Yong He · 2026 · Acta Biomaterialia
  36. A Road Map to Understanding Cardiovascular Disease in Diabetes: From the AHA Strategically Focused Research Network in Cardiometabolic Health and Type 2 Diabetes
    E. Dale Abel, Rexford S. Ahima, Ethan J. Anderson, David D. Berg, Jeffrey S. Berger, Saumya Das, Mark W. Feinberg, Edward A A Fisher, Michael Seth Garshick, Chiara Giannarelli et al. · 2026 · Circulation Research
  37. Lifestyle factors and cardiometabolic risk
    Weiqin Li, Yun Shen, Gang Hu · 2026 · Chinese Medical Journal
  38. Risk Prediction of Chronic Kidney Disease Progression in Type 2 Diabetes Mellitus Across Diverse Populations
    Yubo Zhao, Shuya Lu, JIQIAO LU, Lin Yang, Cheuk Wai Lo, Man Kin Wong, Ting Li, Hui Ren, Xiang Li, Lin Xu et al. · 2026 · npj Digital Medicine
  39. TyG and RC combined with CVD risk in CKM syndrome: A national cohort study
    Hongtao Lan, Xu Jia, Zheng Zhao, Ruolan Chen, Banghui Wang, Changan Qu, Xianming Chu · 2026 · iScience
  40. Cumulative inflammatory index and the risk of cardiometabolic multimorbidity: a prospective cohort study among middle-aged and older adults in China
    Zehao Li, Boqiang Zhong, 徐卫芹, Li Sun, Xiao Hu · 2026 · Journal of Health Population and Nutrition
  41. Frailty as a risk-enhancing factor across the cardiovascular–kidney–metabolic framework: findings from the UK Biobank
    Yanwen Fang, Sizhuang Huang, Hao Zhang, Mingyang Li, Haihua Zhang, Weixian Yang, Mengyue Yu · 2026 · European Journal of Preventive Cardiology
  42. Exploring the relationship between sleep patterns and cardio-renal-metabolic multimorbidity in Chinese and European populations
    Haojie Wang, Saixue Tang · 2026 · Journal of Health Population and Nutrition
  43. Neighborhood Indices, Income, and Cardiovascular-Kidney-Metabolic Syndrome at the Census Tract Level
    Vaishnavi Krishnan, Xiaoning Huang, Cyanna McGowan, Nilay S. Shah, Farah Qureshi, Cynthia S. Minkovitz, Kiarri N. Kershaw, Alexa A. Freedman, Gregory E. Miller, Donald M. Lloyd‐Jones et al. · 2026 · JAMA Network Open
  44. Remnant Cholesterol Inflammatory Index and Its Association With All‐Cause Mortality Among General Population and Individuals With Cardiovascular–Kidney–Metabolic Syndrome Stages 0–3: Evidence From Two Nationwide Studies
    Chen‐Zhang Ou, Zhong-Qiang Liu, Yu‐Jun Xiong, Shiqin Chen, Tian Lv, Jingjing Lou · 2026 · Clinical Cardiology
  45. Persistence-Dependent Effectiveness of Tirzepatide on the Cardio-Metabolic-Kidney Syndrome Outcomes in Obesity: Real-World Evidence from the United Arab Emirates
    Imran Rashid Rangraze, Mohamed El-Tanani El-Tanani, Andrej Janež, Viviana Maggio, Syed Arman Rabbani, Mojca Jensterle, Ana Munda, Elhadi Eltayeb Abbas, Humam Sami Ali, Mohammad Rashid Farooqi et al. · 2026 · Diabetes Therapy
  46. The kidney in the middle: Kidney Disease: Improving Global Outcomes (KDIGO) guidelines address multiple key components of cardiovascular-kidney-metabolic syndrome
    Adeera Levin, Nisha Bansal, Ian H. de Boer, Morgan Erika Grams, Michel Jadoul, Jozine M. ter Maaten, Reem A. Mustafa, Peter R Rossing, Michael Cheung, Jennifer M. King et al. · 2026 · Kidney International
  47. Predicting Risk of Cardiovascular Disease EVENTs Equation for Adverse Cardio-Kidney Outcomes in CKD Population
    Byounghwi Ko, Chan‐Young Jung, Ye Eun Ko, Hee Byung Koh, Cheol Ho Park, Hyung Woo Kim, Jung Tak Park, Seung Hyeok Han, S M Kang, Jayoun Kim et al. · 2026 · Clinical Journal of the American Society of Nephrology
  48. Cardiovascular–kidney–metabolic syndrome through the lens of gut‑derived uremic toxins
    Chudan Xu, Matthew Snelson, Francine Z. Marques · 2026 · Gut Microbes
  49. MASLD and the cardiovascular-kidney-liver-metabolic syndrome
    Angeliki M. Angelidi, Chrysoula Boutari, Michail Kokkorakis, Konstantinos Stefanakis, Dimitri P. Mikhailidis, George Jacob, Christos Socrates Mantzoros · 2026 · Endocrine Reviews
  50. Global and regional projections of atherosclerotic cardiovascular-kidney-liver-metabolic disease burden to 2050: a forecasting analysis for the global burden of disease study 2023
    Jayanth Jayabaskaran, Srinithy Nagarajan, Haryo Raden Himan, Jordan Kok, Ernest En-Rae Tan, Bryan Chong, Gwyneth Kong, Yiming Chen, Han Shi Jocelyn Chew, Muhammad Shahzeb Khan et al. · 2026 · Metabolism
  51. Hyperuricaemia Prevalence Rates According to Their Physiochemical and Epidemiological Diagnostic Criteria and Their Associations with Cardio-Renal-Metabolic Factors: SIMETAP-HU Study
    Antonio Ruiz‐García, Adalberto Serrano-Cumplido, Ezequiel Arranz-Martínez, Carlos Escobar, Vicente Pallarés‐Carratalá · 2024 · Journal of Clinical Medicine
  52. Multimorbidity in elderly patients with or without T2DM: A real-world cross-sectional analysis based on primary care and hospitalisation data
    Yang Li, Shasha Geng, Huixiao Yuan, Jianli Ge, Qingqing Li, Xin Chen, Yingqian Zhu, Yue Liu, Xiaotong Guo, Xiaoli Wang et al. · 2024 · Journal of Global Health
  53. Renal T1 Times on Cardiac Magnetic Resonance Reflect Renal Dysfunction and Are Associated with Adverse Outcomes: Insights from an All-Comer Cohort
    Laura Lunzer, Carolina Donà, Katharina Mascherbauer, Christina Kronberger, Christian Nitsche, Matthias Koschutnik, Michael Poledniczek, Paul Felix Harbich, Christoph Clemens Kaufmann, Edita Pogran et al. · 2024 · Journal of Clinical Medicine
  54. Situación de la enfermedad renal crónica en América Latina, con énfasis en la enfermedad renal diabética: dificultades y desafíos
    Jorge E. Rico-Fontalvo, Alicia Ester Elbert, Eduardo Lorca, Rodrigo Daza-Arnedo, Carlos Castellaro, Vanessa Villavicencio, Guillermo Javier Rosa-Diez, Carlos Bonanno-Hidalgo, Vicente Sánchez-Polo, Ricardo Correa‐Rotter · 2025 · Nefrología Latinoamericana
  55. Lipoprotein Subfractions Predict All-cause and Cardiovascular Mortality in CKD Patients Undergoing Hemodialysis: A Prospective Cohort Study Based on NMR Metabolomics
    Qingxia Huang, Han Zhang, Ziyan Shen, Jing Chen, Xuesen Cao, Linghan Xu, Cheng Zhu, Shiqi Lv, Xixi Yu, Xiaoqiang Ding et al. · 2025 · Phenomics
  56. Time-varying cost-effectiveness analysis of sodium-glucose cotransporter-2 inhibitors in Chinese patients with heart failure and reduced ejection fraction: A microsimulation of the real-world population
    Xinyu Zou, Xingchen He, Qingyang Shi, Si Wang, Nan Li, Yiling Zhou, Ming Hu, Li Luo, Yiwen Shen, Ye Zhu et al. · 2025 · Frontiers in Pharmacology
  57. The effect of cardiovascular–kidney–metabolic disease on pulse pressure in patients with type II diabetes
    Mustafa Jamal Ahmed, Omer Ali, Aisha Siddiqah Ahmed, Wasem Omar, Khalid Ahmed · 2025 · Journal of current cardiology.
  58. Association of the triglyceride–glucose index with all-cause and cardiovascular mortality among individuals with cardiovascular–kidney–metabolic syndrome: a population-based cohort study using data from the US National Health and Nutrition Examination Survey, 1999–2018
    Songfeng Zhao, Jiayue Duan · 2025 · BMJ Open
  59. Identifying clinical phenotype clusters in patients with coronary artery disease
    Joris Holtrop, Carl-Emil Lim, Alicia Uijl, Peter Ueda, Tomas Jernberg, Manon G. van der Meer, Pim van der Harst, Adriaan O. Kraaijeveld, Jan-Willem Balder, Steven H J Hageman et al. · 2025 · Heart
  60. The Role of miR-802 in Diabetic Kidney Disease: Diagnostic and Therapeutic Insights
    Antonio Tejera‐Muñoz, Vanessa A Marchant, Lucía Tejedor-Santamaria, Lucas Opazo-Ríos, Carolina Lavoz, M.J. Gimeno, José Luis Aceña, Marta Ruiz‐Ortega, Raúl R. Rodrigues-Díez · 2025 · International Journal of Molecular Sciences
  61. Historical Redlining and Cardio-Kidney-Metabolic Disease Risk Factors, Prevalence, and Outcomes
    Ramzi Ibrahim, Dwani D. Patel, Hoang Nhat Pham, Mahmoud Hassan Abdelnabi, Girish Pathangey, Issam Kamel Motairek, Khurram Nasir, Sadeer G Al-Kindi · 2025 · JACC Advances
  62. HIF ‐Mediated Fructose Metabolism and Disease Progression in the Cardiovascular‐Kidney‐Metabolic Syndrome
    David Mathew, Sean M. Davidson, Derek M. Yellon · 2025 · Comprehensive physiology
  63. Association Between Serum Advanced Glycation End Products and Cardiovascular‐Kidney‐Metabolic ( CKM ) Syndrome: A 3‐Year Longitudinal Cohort Study (2019–2022)
    Hui Zhao, Z W Zhang, Tao Luo, Dilihumaer Aili, Wen‐huan Ding, Yuanyuan Li, Yan Gu, Aslibek Shulipan, Jingni He, Wen‐hui Yu et al. · 2025 · Journal of Diabetes
  64. Cumulative Cardiovascular Health Score Through Young Adulthood and Cardiovascular and Kidney Outcomes in Midlife
    Jong Hyun Jhee, Kyoung Hwa Ha, Dasom Son, Hyeok‐Hee Lee, Eun‐Jin Kim, Hyeon Chang Kim, Hokyou Lee · 2025 · JAMA Cardiology
  65. Multifactorial chronic kidney disease and the kidney capacity–workload balance
    Paola Romagnani, J. W. S. Chan, Hans‐Joachim Anders · 2026 · Nature Reviews Nephrology
  66. Making treatment guideline recommendations in chronic kidney disease and type 2 diabetes more accessible to primary care providers in the United States
    Eugene E. Wright, Susanne B. Nicholas · 2024 · Postgraduate Medicine
  67. Unsupervised Cluster Analysis in Patients with Cardiorenal Syndromes: Identifying Vascular Aspects
    Jean-Baptiste de Fréminville, Jean‐Michel Halimi, Valentin Maisons, Guillaume Goudot, Arnaud Bisson, Denis Angoulvant, Laurent Fauchier · 2024 · Journal of Clinical Medicine
  68. Assessing athletes beyond routine screening: Incorporating essential factors to optimize cardiovascular health and performance
    Deen L. Garba, Alan P. Jacobsen, Roger Scott Blumenthal, Matthew W. Martinez, Chiadi E. Ndumele, Alexis M. Coslick, Lili A. Barouch · 2024 · American Heart Journal Plus Cardiology Research and Practice
  69. Early metabolic and hemodynamic indicators of kidney dysfunction in mice offspring from parental low protein diet
    Fabiola Diniz, Francesca Edgington-Giordano, Samir Sayem El-Dahr, Giovane G. Tortelote · 2024 · Molecular and Cellular Pediatrics
  70. Impact of metabolic abnormalities on the association between normal-range urinary albumin-to-creatinine ratio and cardiovascular mortality: evidence from the NHANES 1999–2018
    Ming-Hui Li, Rong Ji, Z. Li, Sheng Zhao, Rong Liu, Xi Liu, Yongjian Wu · 2024 · Diabetology & Metabolic Syndrome
  71. American society for preventive cardiology 2024 cardiovascular disease prevention: Highlights and key sessions
    Akhil Avunoori Chandra, Carlos Espiche, Maisha Maliha, Salim S. Virani, Roger Scott Blumenthal, Fátima Rodríguez, Nathan D. Wong, Martha Gulati, Leandro N. Slipczuk, Michael David Shapiro · 2024 · American Journal of Preventive Cardiology
  72. Effects of statins on kidney function in older adults
    Michelle A. Fravel, Michael E. Ernst, Robyn L. Woods, Suzanne Gaye Orchard, Kevan R. Polkinghorne, Rory S Wolfe, James B. Wetmore, Mark Richard Nelson, Elisa K. Bongetti, Anne M. Murray et al. · 2024 · Journal of the American Geriatrics Society
  73. Efficacy of myo‐inositol and zinc on insulin resistance in a paediatric population with obesity
    Valentina Antoniotti, Cristina Partenope, Arianna Solito, Valentina Mancioppi, Jessica Baima, Federico Medina, Sotirios Dimarakis, Alida Agostini, Maria Teresa Sista, Alice Monzani et al. · 2025 · Diabetes Obesity and Metabolism
  74. Difference between estimated glomerular filtration rate based on cystatin C versus creatinine and cardiovascular–kidney–metabolic health
    Xiaoyan Wu, Wuming Hu, Jian Xu, Jiayi Shen, Li Lin, Jingshuai Zhu, Tiemin Wei, Lingchun Lv · 2025 · Frontiers in Medicine
  75. Obesity Phenotypes, Lifestyle Medicine, and Population Health: Precision Needed Everywhere!
    Jean‐Pierre Després, Dominic J. Chartrand, Adrien Murphy-Després, Isabelle Lemieux, Natalie Alméras · 2025 · Journal of Obesity & Metabolic Syndrome
  76. Incorporating the cardiovascular-kidney-metabolic health framework into the local healthcare system: a position statement from the Hong Kong College of Physicians
    Chi‐Ho Lee, GuangMing Tan, Sydney C.W. Tang, YW Ng, Michael KY Lee, Johnny Wai Man Chan, Tak Mao Chan · 2025 · Hong Kong Medical Journal
  77. Sex-Divergent Blood Pressure Associations With Multiorgan System Metabolic Stress—Brief Report
    Alan C. Kwan, Minhao Wang, Hongwei Ji, Brian Lee Claggett, David Ouyang, Hirsh D. Trivedi, Sonia Sharma, John Y.-J. Shyy, Amanda Velazquez, Joseph E. Ebinger et al. · 2025 · Arteriosclerosis Thrombosis and Vascular Biology
  78. From Metabolic Syndrome to Cardio-Kidney-Metabolic Syndrome in the SIMETAP Study: Prevalence Rates of Metabolic Syndrome and Its Independent Associations with Cardio-Renal-Metabolic Disorders Other than Its Defining Criteria
    Antonio Ruiz‐García, Ezequiel Arranz-Martínez, Adalberto Serrano-Cumplido, Sergio Cinza‐Sanjurjo, Carlos Escobar, José Polo García, Vicente Pallarés‐Carratalá · 2025 · Biomedicines
  79. The effect of exercise training on quality of life in people with chronic kidney disease requiring dialysis. A systematic review with meta-analysis
    Annette Traise, G. Dieberg, Elizabeth Degotardi, Bailey Hart, Fiza Kaippilly, D. McInnes, M. Pearson, D. Ryan, N. Smart · 2025 · JN. Journal of Nephrology (Milano. 1992)
  80. A Plant-Based Diet for Cardiovascular Risk Reduction in Kidney Disease with a Focus on Cardiovascular-Kidney-Metabolic Syndrome.
    R. Shi, Mario Mendoza-Sanchez, M. Qadir, S. Joshi · 2025 · Cardiology Clinics
  81. Obesity update: cardiovascular risk and therapeutic innovations (focus on semaglutide and tirzepatide)
    Luca Antonio Felice Di Odoardo, Ottavio Zucchetti, Edoardo Sciatti, Salvatore D’Isa, Emilia D’Elia, Michele Senni · 2025 · European Heart Journal Supplements
  82. ANMCO statement: semaglutide in the cardio-nephro-metabolic continuum
    Leonardo De Luca, Claudio Bilato, Alessandro Navazio, Marco Corda, Massimo Milli, Pietro Scicchitano, Massimo Di Marco, Carmine Riccio, Giovanna Geraci, Attilio Iacovoni et al. · 2025 · European Heart Journal Supplements
  83. Uric acid to high-density lipoprotein cholesterol ratio in association with adverse health outcomes in patients with chronic kidney disease
    Kaixin Lei, Sihan Hu, Yuxuan Zhang, Jiaao Wang, Jun Wang · 2025 · Nutrition Metabolism and Cardiovascular Diseases
  84. Evaluating Cardiovascular-Kidney-Metabolic Syndrome Knowledge in Large Language Models: A Comparative Study of ChatGPT, Gemini, and DeepSeek
    Luxiang Shang, Sha Sha, Yinglong Hou · 2025 · Diabetes Technology & Therapeutics
  85. Isolated diastolic hypertension and incident cardio-renal-metabolic multimorbidity in the Tehran Lipid and Glucose Study: comparison of ACC/AHA and ESC/NICE guideline definitions
    Soroush Masrouri, Amirhossein Hasanpour, Danial Molavizadeh, Navid Ebrahimi, Fereidoun Azizi, Farzad Hadaegh · 2025 · Hypertension Research
  86. Association between cardiovascular-kidney-metabolic health metrics and long-term cardiovascular risk: Findings from the Chinese Multi-provincial Cohort Study
    Ziyu Wang, Xuan Deng, Zhao Yang, Jiangtao Li, Pan Zhou, Wenyan Zhao, Yongchen Hao, Qiuju Deng, Na Yang, Lizhen Han et al. · 2025 · Chinese Medical Journal
  87. Sleep Duration and Cardiometabolic-Kidney-Metabolic Syndrome: The Role of Depressive Symptoms in a Longitudinal Study
    Yixuan Pan, Jingru Bi, Long Feng, Xiaoyun Li · 2025 · Nature and Science of Sleep
  88. Prevention of Cardiovascular Disease — Don’t Stop Thinking about Tomorrow
    Roger Scott Blumenthal, Seth Shay Martin · 2024 · New England Journal of Medicine
  89. Seeking Multiorgan Benefits with Cardiovascular–Kidney–Metabolic Drug Therapy
    Faiez M. Zannad · 2025 · New England Journal of Medicine
  90. Screening, Diagnosis, Evaluation, and Staging of Obesity in Adults: Standards of Care in Overweight and Obesity—2026
    2025 · BMJ Open Diabetes Research & Care
  91. Cardiovascular-Kidney-Metabolic Syndrome: Population and Policy Implications: 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome
    LaPrincess C. Brewer, Joshua J. Joseph, Lisa A. Cooper · 2026 · Circulation
  92. Discontinuation of SGLT2i in people with type 2 diabetes following hospitalisation for heart failure: A cause for concern?
    Tamara Y. Milder, Jialing Lin, Sallie‐Anne Pearson, Juliana de Oliveira Costa, Brendon Lange Neuen, Carol A. Pollock, Min Jun, Jerry Richard Greenfield, Richard Osborne Day, SOPHIE LENA STOCKER et al. · 2024 · Diabetes Obesity and Metabolism
  93. Association between admission serum calcium levels and in‑hospital mortality in acute myocardial infarction patients with cardiovascular-kidney-metabolic syndrome
    Jing Xu, Shuai Yu, Jian Huang, Geng Li, Yumiao Wei, Xin Li, Xin Gong · 2025 · Endocrine
  94. Increasing incidence of hypertensive disorders of pregnancy and association with decreased GFR and albuminuria: The need for post-partum follow-up
    Carolina Gracia-Iguacel, Manuel Perez Toran, Miguel Álvaro Navidad, Begoña Gómez Pérez, José Miguel Arce-Obieta, Cristina Morocho-Pindo, Emilio González‐Parra, Ignacio Mahíllo, Alberto Ortíz · 2025 · Placenta
  95. Finerenone: Potential Clinical Application Across the Spectrum of Cardiovascular Disease and Chronic Kidney Disease
    Nowreen Haq, Pulkita Uppal, Taslova Abedin, Anuradha Lala · 2025 · Journal of Clinical Medicine
  96. Pediatric Chronic Kidney Disease: Mind the Gap Between Reality and Expectations
    Chien‐Ning Hsu, Pei‐Chen Lu, Wei-Ting Liao, You‐Lin Tain · 2025 · Children
  97. External validation of the 2023 American Heart Association Predicting Risk of cardiovascular disease EVENTs equations for atherosclerotic cardiovascular disease in primary cardiovascular prevention setting and comparison with 2021 Systematic COronary Risk Evaluation and 2013 Pooled Cohort Equations
    Roxane de La Harpe, Pedro Manuel Marques-Vidal, Julien Vaucher · 2025 · European Journal of Preventive Cardiology
  98. Cardiovascular-kidney-metabolic syndrome, systemic inflammation, and incident dementia: evidence from 400,740 UK Biobank participants
    Pingan Li, Haiping Zhang, Jianhua Ma, Jinqi Wang, Shiyun Lv, Xiaoyu Zhao, Xinghua Yang, Yanxia Luo, Xiuhua Guo, Lixin Tao et al. · 2025 · Diabetology & Metabolic Syndrome
  99. County-level modeled extreme heat risk and premature all-cause mortality related to cardio-kidney-metabolic syndrome in the United States: A cross-sectional analysis
    Kerwin Cayton, Zhuo Chen, Tong Zhang, Barrak Alahmad, Yazan Alwadi, Sadeer G Al-Kindi, Khurram Nasir, Sanjay Rajagopalan, Haitham Khraishah, Salil Vasudeo Deo · 2025 · American Journal of Preventive Cardiology
  100. Association between the dietary inflammatory index and depressive symptoms in adults with cardiovascular–kidney–metabolic syndrome: evidence of metabolic syndrome as a mediator
    Ruo-Nan Tian, Sheng‐Xiao Zhang, Nan Zhang, Wen-Jing Wu, Hua-Qing Guo, Chen Wang, Zhi-Guang Duan · 2025 · Frontiers in Nutrition